Stocksigma LogoStocksigma Logo

Molbio Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 2,590 (-55.4% YoY | -36.6% QoQ) ■ EBITDA: 439 (-73.9% YoY | -56.3% QoQ) ■ EBITDA Margin (%): 17.0 (-1202 bps YoY | -766 bps QoQ) ■ PAT: 151

Molbio Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Molbio Diagnostics Ltd · Outcome · 05 Nov 2026, 11:01 pm

Molbio Diagnostics Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 2,590 (-55.4% YoY | -36.6% QoQ) ■ EBITDA: 439 (-73.9% YoY | -56.3% QoQ) ■ EBITDA Margin (%): 17.0 (-1202 bps YoY | -766 bps QoQ) ■ PAT: 151 (-86.2% YoY | -74.3% QoQ) ■ EPS (INR): 1.33 (-86.3% YoY | -74.5% QoQ)

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements